Bumper Offer - Urjas oil Just @ Rs. 1 X
StayHappi Montelukast 5 Mg Mouth Dissolving Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when StayHappi Montelukast 5 Mg Mouth Dissolving Tablet is used -
Mild
Common
Is the use of StayHappi Montelukast 5 Mg Mouth Dissolving Tablet safe for pregnant women?
It is not known what effect StayHappi Montelukast Tablet will have on pregnant women, because no research work has been carried out on this till date.
Is the use of StayHappi Montelukast 5 Mg Mouth Dissolving Tablet safe during breastfeeding?
There is no research available on the side effects of StayHappi Montelukast Tablet in breastfeeding women. Therefore, its impact is unknown.
What is the effect of StayHappi Montelukast 5 Mg Mouth Dissolving Tablet on the Kidneys?
StayHappi Montelukast Tablet rarely affects the kidneys.
What is the effect of StayHappi Montelukast 5 Mg Mouth Dissolving Tablet on the Liver?
StayHappi Montelukast Tablet can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of StayHappi Montelukast 5 Mg Mouth Dissolving Tablet on the Heart?
StayHappi Montelukast Tablet has very mild side effects on the heart.
StayHappi Montelukast 5 Mg Mouth Dissolving Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take StayHappi Montelukast 5 Mg Mouth Dissolving Tablet unless your doctor advises you to do so -
Is this StayHappi Montelukast 5 Mg Mouth Dissolving Tablet habit forming or addictive?
Forming a habit of StayHappi Montelukast 5 Mg Mouth Dissolving Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking StayHappi Montelukast 5 Mg Mouth Dissolving Tablet since it will not make you feel sleepy.
Is it safe?
Yes, but take StayHappi Montelukast 5 Mg Mouth Dissolving Tablet only as per medical advice.
Is it able to treat mental disorders?
No, StayHappi Montelukast 5 Mg Mouth Dissolving Tablet is not used to treat mental disorders.
Interaction between Food and StayHappi Montelukast 5 Mg Mouth Dissolving Tablet
Information is not available on the interaction of any foods with StayHappi Montelukast 5 Mg Mouth Dissolving Tablet, due to a lack of research on this.
Interaction between Alcohol and StayHappi Montelukast 5 Mg Mouth Dissolving Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking StayHappi Montelukast 5 Mg Mouth Dissolving Tablet.
No, StayHappi Montelukast Tablet should not be applied to children under the age of 2 years as the safety and efficacy have not been established yet in this age group.
StayHappi Montelukast Tablet may cause delayed weight gain and slowed growth in children on whom it is used topically. Therefore, you must talk to a doctor before using StayHappi Montelukast Tablet on children.
StayHappi Montelukast Tablet is available as a cream, lotion or an ointment. It is generally applied once a day. It should be applied every day at the same time. The instructions of the doctor and those given on the prescription label should be followed properly. One must not apply it more often than prescribed and it must not be applied to other areas of the skin. The skin condition should improve in 2 weeks times. A thin layer of cream or ointment should be applied and a few drops of lotion should be applied to the affected area. It is only to be applied on the skin. It should not be applied on mouth or eyes and should not be swallowed. Its use should be avoided on the genital, rectal areas, skin creases and armpits unless otherwise specified by your doctor. Do not apply any other cream, ointment or lotion on the treated area and do not cover it with bandage or cloth unless directed by your doctor.
StayHappi Montelukast Tablet is a medium potency synthetic corticosteroid with anti-inflammatory, antipruritic (used to relieve itching) and vasoconstrictive (narrowing of the blood vessels) activity. It is effective for the treatment of asthma. It is also used topically for the management of skin disorders like psoriasis (red scaly patches on some areas of the body) and eczema (dry and itchy skin with red and scaly patches). It is generally available as a furoate salt.
No, StayHappi Montelukast Tablet is not recommended to be used for ringworm. Ringworm is a fungal infection and it is not caused by any worm. It presents as a silver or red colored patch which may be swollen, itchy, scaly or dry. Ringworm can manifest in any part of the body, including groin (jock itch) and scalp (tenia capitis). The rash is usually ring-shaped on places other than face, neck or scalp. At times, the rash starts spreading. It should be treated using antifungal creams containing ingredients like clotrimazole, miconazole, etc.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 359-360
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Elocon® (mometasone furoate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nasonex® (mometasone furoate monohydrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Asmanex® Twisthaler® (mometasone furoate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)